TY  - JOUR
AU  - Tenorio-Jiménez, Carmen
AU  - Martínez-Ramírez, María José
AU  - Tercero-Lozano, Mercedes
AU  - Arraiza-Irigoyen, Carmen
AU  - Del Castillo-Codes, Isabel
AU  - Olza, Josune
AU  - Plaza-Díaz, Julio
AU  - Fontana, Luis
AU  - Migueles, Jairo H
AU  - Olivares, Mónica
AU  - Gil, Ángel
AU  - Gomez-Llorente, Carolina
PY  - 2018
DO  - 10.1186/s12906-018-2371-x
UR  - http://hdl.handle.net/10668/13209
T2  - BMC complementary and alternative medicine
AB  - Obesity is characterized by increased fat mass and is associated with the development of insulin resistance syndrome (IRS), usually known as metabolic syndrome. The alteration of the intestinal microbiota composition has a role in the development of...
LA  - en
KW  - Human adults
KW  - Insulin resistance syndrome
KW  - Lactobacillus reuteri V3401
KW  - Non-alcoholic fatty liver disease
KW  - Obesity
KW  - Probiotics
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Biomarkers
KW  - Cardiovascular Diseases
KW  - Double-Blind Method
KW  - Fatty Liver
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - Humans
KW  - Insulin Resistance
KW  - Limosilactobacillus reuteri
KW  - Male
KW  - Metabolic Syndrome
KW  - Middle Aged
KW  - Obesity
KW  - Probiotics
KW  - Risk Factors
KW  - Young Adult
TI  - Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
TY  - research article
VL  - 18
ER  -